enzyme replacement therapy (biOasis)

N/A

Report date: 2025/01/26 19:24:40

Base Information

Drug Nameenzyme replacement therapy (biOasis)
Drug Alias NameIduronate-2-Sulfatase Fusion Protein (biOasis)MTf-I2S/MTfp-I2S (biOasis)fMTf-HEXBxB3-IDS fusion proteinfMTfp-HEXB
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Enzyme
Mechanisms of ActionEnzymes stimulants
TargetsEnzymes
Therapy Area/IndicationsLysosomal Storage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioasis Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioasis Technologies Inc
Inactive CompaniesN/A
Active IndicationsLysosomal Storage Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A